1
|
Kim KM, Kang DW, Moon WS, Park JB, Park
CK, Sohn JH, Jeong JS, Cho MY, Jin SY, Choi JS and Kang DY;
Gastrointestinal Stromal Tumor Committee; Korean Gastrointestinal
Pathology Study Group. Gastrointestinal stromal tumors in Koreans:
it’s incidence and the clinical, pathologic and immunohistochemical
findings. J Korean Med Sci. 20:977–984. 2005.
|
2
|
Tryggvason G, Gíslason HG, Magnússon MK
and Jónasson JG: Gastrointestinal stromal tumors in Iceland,
1990–2003: the icelandic GIST study, a population-based incidence
and pathologic risk stratification study. Int J Cancer.
117:289–293. 2005.
|
3
|
Goettsch WG, Bos SD, Breekveldt-Postma N,
Casparie M, Herings RM and Hogendoorn PC: Incidence of
gastrointestinal stromal tumours is underestimated: results of a
nation-wide study. Eur J Cancer. 41:2868–2872. 2005. View Article : Google Scholar : PubMed/NCBI
|
4
|
Miettinen M and Lasota J: Histopathology
of gastrointestinal stromal tumor. J Surg Oncol. 104:865–873. 2011.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Hirota S, Isozaki K, Moriyama Y, et al:
Gain-of-function mutations of c-kit in human gastrointestinal
stromal tumors. Science. 279:577–580. 1998. View Article : Google Scholar : PubMed/NCBI
|
6
|
Heinrich MC, Corless CL, Duensing A, et
al: PDGFRA activating mutations in gastrointestinal stromal tumors.
Science. 299:708–710. 2003. View Article : Google Scholar : PubMed/NCBI
|
7
|
Emory TS, Sobin LH, Lukes L, Lee DH and
O’Leary TJ: Prognosis of gastrointestinal smooth-muscle (stromal)
tumors: dependence on anatomic site. Am J Surg Pathol. 23:82–87.
1999. View Article : Google Scholar : PubMed/NCBI
|
8
|
Lerma E, Oliva E, Tugués D and Prat J:
Stromal tumours of the gastrointestinal tract: a
clinicopathological and ploidy analysis of 33 cases. Virchows Arch.
24:19–24. 1994.PubMed/NCBI
|
9
|
Rudolph P, Gloeckner K, Parwaresch R,
Harms D and Schmidt D: Immunophenotype, proliferation, DNA ploidy,
and biological behavior of gastrointestinal stromal tumors: a
multivariate clinicopathologic study. Hum Pathol. 29:791–800. 1998.
View Article : Google Scholar
|
10
|
Ando N, Goto H, Niwa Y, et al: The
diagnosis of GI stromal tumors with EUS-guided fine needle
aspiration with immunohistochemical analysis. Gastrointest Endosc.
55:37–43. 2002. View Article : Google Scholar : PubMed/NCBI
|
11
|
Lewin KJ, Riddell RH and Weinstein WM:
Gastrointestinal Pathology and its Clinical Implications.
Igaku-Shoin; New York, NY: pp. 284–341. 1992
|
12
|
Wang CZ, Hou YY, Shen KT, et al:
Clinicopathological feature and prognosis of cystic
gastrointestinal stromal tumor. Chin J Gastro Surg. 14:599–602.
2011.PubMed/NCBI
|
13
|
Hou YY and Zhu ZX: Malignant degree of
gastrointestinal stromal tumor and the impact on biological
behavior. Chin J Pract Surg. 30:265–269. 2010.
|
14
|
Kim HC, Lee JM, Kim SH, et al: Small
gastrointestinal stromal tumours with focal areas of low
attenuation on CT: pathological correlation. Clin Radiol.
60:384–388. 2005. View Article : Google Scholar : PubMed/NCBI
|
15
|
Bechtold RE, Chen MY, Stanton CA, Savage
PD and Levine EA: Cystic changes in hepatic and peritoneal
metastases from gastrointestinal stromal tumors treated with
Gleevec. Abdom Imaging. 28:808–814. 2003. View Article : Google Scholar
|